Nattachai Srisawat1, John A Kellum. 1. Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Abstract
PURPOSE OF REVIEW: Acute kidney injury (AKI) is a common clinical syndrome whose definition has standardized as a result of consensus by leading experts around the world. As a result of these definitions, reported AKI incidences can now be compared across different populations and settings. Evidence from population-based studies suggests that AKI is nearly as common as myocardial infarction, at least in the western world. This review aims to highlight the recent advances in AKI epidemiology as well as to suggest future directions for prevention and management. RECENT FINDINGS: This review will focus on the recent studies exploring the AKI epidemiology in and outside the ICU. In particular, the risk of AKI in less severe sepsis is notable as is evidence linking AKI to chronic kidney disease. New emphasis on renal recovery is shaping current thinking as is the use and utility of new biomarkers. SUMMARY: This article reviews the recent information about the definition, classification, and epidemiology of AKI. Although new biomarkers are being developed, the 'tried and true' markers of serum creatinine and urine output, disciplined by current criteria, will be important components in the definition and classification of AKI for some time to come.
PURPOSE OF REVIEW: Acute kidney injury (AKI) is a common clinical syndrome whose definition has standardized as a result of consensus by leading experts around the world. As a result of these definitions, reported AKI incidences can now be compared across different populations and settings. Evidence from population-based studies suggests that AKI is nearly as common as myocardial infarction, at least in the western world. This review aims to highlight the recent advances in AKI epidemiology as well as to suggest future directions for prevention and management. RECENT FINDINGS: This review will focus on the recent studies exploring the AKI epidemiology in and outside the ICU. In particular, the risk of AKI in less severe sepsis is notable as is evidence linking AKI to chronic kidney disease. New emphasis on renal recovery is shaping current thinking as is the use and utility of new biomarkers. SUMMARY: This article reviews the recent information about the definition, classification, and epidemiology of AKI. Although new biomarkers are being developed, the 'tried and true' markers of serum creatinine and urine output, disciplined by current criteria, will be important components in the definition and classification of AKI for some time to come.
Authors: D J Askenazi; Michael Heung; Michael J Connor; Rajit K Basu; Jorge Cerdá; Kent Doi; Jay L Koyner; Azra Bihorac; Ladan Golestaneh; Anitha Vijayan; Mark D Okusa; Sarah Faubel Journal: Blood Purif Date: 2016-12-03 Impact factor: 2.614
Authors: Sanjeev Noel; Maria N Martina; Samatha Bandapalle; Lorraine C Racusen; Haranatha R Potteti; Abdel R A Hamad; Sekhar P Reddy; Hamid Rabb Journal: J Am Soc Nephrol Date: 2015-08-20 Impact factor: 10.121
Authors: Sara Nisula; Kirsi-Maija Kaukonen; Suvi T Vaara; Anna-Maija Korhonen; Meri Poukkanen; Sari Karlsson; Mikko Haapio; Outi Inkinen; Ilkka Parviainen; Raili Suojaranta-Ylinen; Jouko J Laurila; Jyrki Tenhunen; Matti Reinikainen; Tero Ala-Kokko; Esko Ruokonen; Anne Kuitunen; Ville Pettilä Journal: Intensive Care Med Date: 2013-01-05 Impact factor: 17.440
Authors: Peter A McCullough; Josee Bouchard; Sushrut S Waikar; Edward D Siew; Zoltan H Endre; Stuart L Goldstein; Jay L Koyner; Etienne Macedo; Kent Doi; Salvatore Di Somma; Andrew Lewington; Ravi Thadhani; Raj Chakravarthi; Can Ice; Mark D Okusa; Jacques Duranteau; Peter Doran; Li Yang; Bertrand L Jaber; Shane Meehan; John A Kellum; Michael Haase; Patrick T Murray; Dinna Cruz; Alan Maisel; Sean M Bagshaw; Lakhmir S Chawla; Ravindra L Mehta; Andrew D Shaw; Claudio Ronco Journal: Contrib Nephrol Date: 2013-05-13 Impact factor: 1.580